Background

Robotic Vacuums. The International Trade Commission has instituted investigation 337-TA-1057 to determine whether imports of robotic vacuum cleaning devices and components thereof, such as spare parts, are violating Section 337 of the 1930 Tariff Act by reason of patent infringement.

Complainant iRobot Corporation requests that after this investigation the ITC issue a limited exclusion order, which would direct U.S. Customs and Border Protection to prohibit the entry of infringing products into the U.S., and cease and desist orders, which would require the named respondents to cease actions that violate Section 337, including selling infringing imported articles out of U.S. inventory. The respondents in this investigation are located in Canada, China, Taiwan, and the U.S.

Radiotherapy Systems. The ITC has terminated patent infringement investigation 337-TA-968 of radiotherapy systems and treatment planning software, and components thereof, without the imposition of import restrictions. This termination is based on a settlement agreement between complainants Varian Medical Systems Inc. and Varian Medical Systems International AG and the respondents, which are located in Sweden, the United Kingdom, Germany, China, and the U.S.

Air Mattress Systems. In patent infringement investigation 337-TA-971 the ITC has determined that the importation, sale for importation, and sale within the U.S. after importation of air mattress systems, components thereof, and methods of using the same are violating patent claims asserted by Select Comfort Corporation and Select Comfort SC Corporation. As a result, the ITC has issued a limited exclusion order prohibiting the unlicensed entry of infringing goods that are manufactured abroad or imported by or on behalf of the respondents or their affiliated companies, parents, subsidiaries, or other related business entities or their successors or assigns. The ITC has also determined that the amount of the bond under which infringing goods may continue to enter the U.S. during the 60-day presidential review period should be zero.

Close

Cookie Consent

We use cookies on our website. By continuing to use our website, you agree to the Privacy Policy and Terms of Use.